BMY vs NVO
Bristol-Myers Squibb Company · Novo Nordisk A/S
Relative return (rebased to 100)
Key stats
| Metric | BMY | NVO |
|---|---|---|
| Price | $62.14 | $40.31 |
| Market Cap | $127.02B | $179.14B |
| P/E | 18.01 | — |
| P/B | 5.43 | — |
| P/S | 2.64 | — |
| ROE | 30.1% | — |
| Net Margin | 14.6% | — |
| Gross Margin | 63.8% | — |
| Revenue Growth | -0.2% | — |
| Dividend Yield | 4.01% | — |
| EPS | $3.45 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.